Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Blind Trust: How Parents with a Sick Child Can Escape the Lies, Hypocrisy and False Promises of Researchers and the Regulatory Authorities

by Klaus Rose
Save 41% Save 41%
Current price ₹1,273.00
Original price ₹2,150.00
Original price ₹2,150.00
Original price ₹2,150.00
(-41%)
₹1,273.00
Current price ₹1,273.00

Imported Edition - Ships in 12-14 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9781781612026
  • Binding: Paperback
  • Subject: N/A
  • Publisher: Hammersmith Books Limited
  • Publisher Imprint: Hammersmith Books Limited
  • Publication Date:
  • Pages: 240
  • Original Price: GBP 16.99
  • Language: English
  • Edition: N/A
  • Item Weight: 409 grams
  • BISAC Subject(s): Children & Adolescents

An insider's look into the world of pediatric drug trials: when research outcomes can quite literally represent life or death

Many parents of children with serious health problems may wonder why new medicines are initially not approved for minors and, if their condition is rare, why at the same time there is such pressure to enter any young person under 18 into drug trials. So-called 'paediatric' pharmaceutical studies have become an international multi-billion business, with many careers in academia, regulatory authorities and the pharmaceutical industry based on this work, yet much of this activity is founded on a series of flawed concepts that have led to an immeasurable waste of resources and serious, ongoing medical abuse. In this revelatory book, the former head of paediatric drug research at two major pharmaceutical companies provides a guide for parents and non-specialists interested in advancing the health of children--both individuals facing serious disease and groups of children enrolled in testing programs. Rose explains the key differences between clinically-directed and administratively-directed research, what will potentially benefit or harm children, and how laws need to change around the world so that true advances can be made.

Rose, Klaus: -

Klaus Rose MD MS is a medical doctor who worked in the pharmaceutical industry for 20 years. He was an enthusiast for pharmaceutical studies in children and became global head of paediatric research first at Novartis and then Genentech/Roche before becoming an independent advisor on paediatric studies for drug approval in 2011. Through this work he came to understand that a large proportion of 'investigations' in children are not only unnecessary but ethically questionable, and that these problems are masked by a stated intention of 'helping children' that is hard to challenge.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us